Molecular cancer
A large open access journal for laboratory cancer research, from tumour signalling and the microenvironment to biomarkers and new therapeutic approaches.
Overview
Molecular Cancer is an open access, peer-reviewed journal published by BMC, part of Springer Nature, with Christophe Nicot of Kansas University Medical Center as Editor-in-Chief. The journal states that it is interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science, and it runs themed article collections, for example on nanomedicine for cancer therapy, cellular senescence and cancer, immunotherapy, liquid biopsy, genome editing and phase 2 and 3 studies. DOAJ lists it with CC BY and CC BY-NC-ND licences, an article processing charge, anonymous peer review and open access content from 2002. NLM records the journal as starting in 2002, published in London, and currently indexed in MEDLINE.
Physician who directs Siriraj Hospital, Thailand's oldest and largest hospital and the teaching hospital of Mahidol University's Faculty of Medicine Siriraj Hospital.
Built China's flagship biotherapy laboratory, a source of cancer vaccines, gene therapies, and biologics.
Pages like this
not linked directly; found by shared links- JournalJournal of surgical oncology
- JournalJournal of hematology & oncology
Shares Yuquan Wei, PubMed & Europe PMC.